MicroMass President Named Top 100 in Pharma
CARY, N.C. - Jay Bigelow, President of MicroMass Communications, Inc., a leader in behavioral science-based relationship marketing, has been selected by PharmaVOICE magazine as one of the 100 most inspiring and influential people in the life sciences industry.
The honor was announced in the July/August issue of PharmaVOICE, which annually pays tribute to top leaders in all areas of the pharmaceutical industry. Candidates were nominated by peers, then evaluated by a panel of PharmaVOICE editors on the basis of their demonstrated ability to inspire, motivate and influence corporate leadership, research and development, technology, creativity, marketing and strategy in the life sciences industry. Nominees were also evaluated on their commitment and service to their employees, companies and communities.
MicroMass developed the first patient-support program to demonstrate that the application of proven behavioral science models, coupled with personalized MicroMass President Jay Bigelow Named to PharmaVOICE 100 communications via mass media channels, could change attitudes and behavior in measurable ways for positive health outcomes. This seminal program, launched in 1996, laid the foundation for the dramatic transformation of MicroMass from a small technology company to a leader in healthcare relationship marketing.
The editors also cited Bigelow's commitment to others as a reason for his selection to the PharmaVOICE 100. "He spurs the company to reach for higher ideas and insights to enable pharma clients to help their patients achieve a healthier quality of life," they wrote, adding that he also fosters professional growth and development among his colleagues, championing courage, honesty and integrity.
Visit http://www.micromass.com/news/in_the_know.jsp# to read full details on Bigelow's selection to the PharmaVOICE 100.
About MicroMass Communications, Inc.: MicroMass personalizes brands. Founded in 1994, MicroMass is a relationship marketing agency with unrivalled capabilities in the use of behavioral science for gaining and applying deep consumer insights. The company's approach is founded on MicroMass President Jay Bigelow Named to PharmaVOICE 100 the belief that understanding the critical factors that influence individual behavior and creating a dialogue that addresses those factors is the best way of building enduring relationships between customers and brands.
Unlike traditional agencies that are "siloed" or structured by discipline, MicroMass brings together under one roof the expertise and services for building sophisticated, multi-channel programs that span the full relationship marketing continuum.
Headquartered in Cary, N.C., with a second office in Morristown, N.J., MicroMass is one of the fastest growing agencies in its field. With experience in more than 30 therapeutic categories, the company has a roster of clients that includes GlaxoSmithKline, Johnson & Johnson, LabCorp, Merck & Co., Inc., Novartis, Shire and UCB Pharma.
For additional information on MicroMass, visit http://www.micromass.com.